This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lalwani, N. D. Articles by De La Iglesia, F. A. Search for Related Content PubMed PubMed Citation Articles by Lalwani, N. D. Articles by De La Iglesia, F. A. Social Bookmarking                         What's this?

Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver

Pathology & Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105

Lloyd A. Dethloff

Pathology & Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105

Jeffrey R. Haskins

Pathology & Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105

Donald G. Robertson

Pathology & Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105

Felix A. De La Iglesia

Pathology & Experimental Toxicology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan 48105

Peroxisome proliferators are believed to induce liver tumors in rodents due to sustained increase in cell proliferation and oxidative stress resulting from the induction of peroxisomal enzymes. The objective of this study was to conduct a sequential analysis of the early changes in cell-cycle kinetics and the dynamics of rat liver DNA synthesis after treatment with a peroxisome proliferator. Immunofluorescent detection of proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) incorporation into DNA during S phase were used to assess rat hepatocyte proliferation in vivo during dietary administration of Wy-14,643, a known peroxisome proliferator and hepatocarcinogen in rodents. Rats were placed on a diet containing 0.1% Wy-14,643 and implanted subcutaneously with 5-bromo-2'-deoxyuridine containing osmotic pumps 4 days prior to being sacrificed on days 4, 11, and 25 of treatment. Isolated liver nuclei labeled with fluorscein isothiocyanate (FITC)-anti-BrdU/PI and FITC-anti-PCNA/PI were analyzed for S-phase kinetics using flow cytometry. Morphometric analysis was performed to evaluate nuclear and cell size and enumeration of BrdU labeled cells, binucleated hepatocytes, and mitotic index. The BrdU labeling index increased 2-fold in livers of Wy-14,643-treated rats at day 4, but distribution of cells in G₁, S phase, and G ₂-M did not differ significantly from controls. PCNA-positive cells decreased from 36% on day 4 to 17% on day 25, whereas the percentage of PCNA-positive cells in controls increased 2-fold from day 4 to day 11 and remained unchanged up to day 25. The differences in the number of PCNA-positive nuclei between control and Wy-14,643-treated groups were statistically significant only on day 4. Binucleated hepatocytes, determined by morphometric analysis, increased slightly on day 25 in treated rats parallel to an increase in the percentage of cells in G₂-M phase. Significant shifts were noted in nuclear diameter and nuclear area after 11 and 25 days of treatment with Wy-14,643. Hepatic cell populations with nuclei >9 µm diameter and nuclear area >64 µm² increased in Wy-14,643-fed rats during the treatment period compared with the control, indicating hepatic karyomegaly and hyperploidy, whereas percentage of distribution of nuclei based on diameter and area remained consistently unchanged in control animals from 4 through 25 days of sham treatment. The flow cytometric and morphometric analysis indicated an initial wave of DNA synthesis in response to Wy-14,643. The hepatomegaly was sustained over the treatment period accompanied by increase in ploidy with a significant shift toward hyperploidic hepatocytes. The increase in DNA content was almost entirely accounted for by the overall polyploidy increase rather than by an absolute increase in cells.

Key Words: Bromodeoxyuridine incorporation • DNA synthesis • cell-cycle analysis • S phase • proliferating cell nuclear antigen • hypolipidemic compounds • Wy-14,643 • peroxisomes • hepatocarcinogenesis • nongenotoxic carcinogens

• Bentley P., Calder F., Elcombe C., Grasso P., Stringer D., and Weigand HJ (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31: 857-907.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bieber LL and Fiol C. (1986). Purification and assay of carnitine acyltransferase. Methods Enzymol 123: 276-284.[Web of Science][Medline] [Order article via Infotrieve]
• Bravo R. and McDonald-Bravo H. (1987). Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J. Cell. Biol. 105: 1549-1554.[Abstract/Free Full Text]
• Brott DA, Alvey JD, Bleavins MR, de la Iglesia FA, and Lalwani ND (1993). Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2 kinase in mouse T-lymphoma cells. J. Cell. Biochem. 52: 362-372.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bums ER, Bagwell CB, Hinson WG, Pipkin JL, and Hudson JL (1983). Preparation and stability of sixteen murine tissues and organs for flow cytometric cell cycle analysis. Cytometry 4: 150-160.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Butterworth BE (1990). Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat. Res. 239: 117-132.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Bybee A., Styles JA, Beck SL, and Blackburn D. (1990). Mitosis and histopathology in rat liver during methylclofenapate-induced hyperplasia. Cancer Lett. 52: 95-100.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Cattley RC and Popp JA (1989). Differences between the promoting activities of the peroxisome proliferator, Wy-14,643 and phenobarbital in rat liver. Cancer Res. 49: 3246-3251.[Abstract/Free Full Text]
• Chen ZY, Liu YF, He CY, White CC, and Eaton DL (1994). Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules. Cancer Res. 54: 2622-2629.[Abstract/Free Full Text]
• Chu S., Huang Q., Alvares K., Yeldandi AV, Rao MS, and Reddy JK (1995). Transformation of mammalian cells by overexpressing H2O2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sci USA 92: 7080-7084.[Abstract/Free Full Text]
• Coltrera MD and Gown AM (1991). PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J. Histochem. Cytochem. 39: 23-30.[Abstract]
• Committee of Care and Use of Laboratory Animals (1985). Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, National Institute of Health, Public Health Services, U.S. Department of Health and Human Services, Washington, D.C.
• Dean P. and Jett J. (1974). Mathematical analysis of DNA distributions derived from flow micro-fluorimetry. Cell Biol. 60: 523-529.[CrossRef]
• Dietrich DR (1993). Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit. Rev. Toxicol. 23: 77-109.[Web of Science][Medline] [Order article via Infotrieve]
• Dietrich DR and Swenberg JA (1991). The presence of 2u-globulin is necessary for D-limonene promotion of male rat kidney tumors. Cancer Res. 51: 3512-3521.[Abstract/Free Full Text]
• Eacho PI, Lanier TL, and Brodhecker CA (1991). Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of Wy-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis 12: 1557-1561.[Abstract/Free Full Text]
• Eldrige SR, Tilbury LF, Goldsworthy TL, and Butterworth BE (1990). Measurement of chemically induced cell proliferation in rodent liver and kidney: A comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administration by injection or osmotic pump. Carcinogenesis 11: 2245-2251.[Abstract/Free Full Text]
• Gerlyng P., Crotomol T., Erikstein B., Stokke T., and Seglen PO (1992). Reduced proliferative activity of polyploid cells in hepatocellular carcinoma. Carcinogenesis 13: 1795-1801.[Abstract/Free Full Text]
• Gerlyng P., Stokke T., Huitfeldt HS, Stenersen T., Danielsen HE, Grotmol T., and Seglen PO (1992). Analytical methods for the study of liver cell proliferation. Cytometry 13: 404-415.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Grasso P. and Hinton RH (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in rodent liver. Mutat. Res. 248: 271-290.[Web of Science][Medline] [Order article via Infotrieve]
• Gratzner HG (1982). Monoclonal antibody to 5-bromo-/and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474-475.[Abstract/Free Full Text]
• Greenwell A., Foley JF, and Maronport RR (1993). Detecting proliferating cell nuclear antigen in archival rodent tissues. Env. Health Perspect. 101(suppl.5): 207-209.
• Gustafsson JA, Gering K., Widmark E., Tollet P., Stromstedt M., Berge RK, and Gottlicher M. (1994). Effects of fatty acids on gene expression mediated by a member of the nuclear receptor supergene family. Prog. Clin. Biol. Res. 387: 21-28.[Web of Science][Medline] [Order article via Infotrieve]
• Isseman I. and Green S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 347: 645-650.[CrossRef][Medline] [Order article via Infotrieve]
• Kasai, H., Okada Y., Nishimura S., Rao, MS, and Reddy JK (1989). Formation of 8-hydroxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 49: 2603-2605.[Abstract/Free Full Text]
• Lanier TL, Berger EK, and Eacho PI (1989). Comparison of 5-bromo-2-deoxyuridine and [3H]thymidine for studies of hepatocellular proliferation in rodents. Carcinogenesis 10: 1341-1343.[Abstract/Free Full Text]
• Lazarow PB (1981). Assay of peroxisomal β-oxidation of fatty acids. Methods Enzymol. 72: 315-319.[Medline] [Order article via Infotrieve]
• Lefevre PA, Tinwell H., Galloway SM, Hill R., Mackay JM, Elcombe CR, Foster J., Randall V., Callander RD, and Ashby J. (1994). Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice. Human Exp. Toxicol. 13: 764-775.[Abstract/Free Full Text]
• Lombardi B., Chander N., and Locker J. (1991). Nutritional model of hepatocarcinogenesis. Rats fed a choline-devoid diet. Digest Des. Sci. 36: 979-984.[CrossRef]
• Loury DJ, Goldsworthy TL, and Butterworth BE (1987). The value of measuring cell replication as a predictive index of tissue-specific tumorigenic potential. Banbury Rep. 25: 119-136.
• Marsman DS and Popp JA (1994). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 15: 111-117.[Abstract/Free Full Text]
• Marsman DS, Cattley RC, Conway JG, and Popp JA (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferator di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48: 6739-6744.[Abstract/Free Full Text]
• Melchiorri C., Chieco P., Zedda AI, Coni P., Ledda-Coulambano GM, and Coulambano A. (1993). Ploidy and nuclearity of rat hepatocytes after compendatory regenerative or mitogen-induced liver growth. Carcinogenesis 14: 1825-1830.[Abstract/Free Full Text]
• Melnick RA (1992). Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J. 6: 2698-2706.[Abstract]
• Nilsson R., Beije B., Preat V., Erixon K., and Ramel C. (1991). On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem. Biol. Interact. 78: 235-250.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rao MS, Lalwani ND, and Reddy JK (1984). Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643)-induced carcinogenesis. J. Natl. Cancer Inst. 73: 983-990.[Web of Science][Medline] [Order article via Infotrieve]
• Rao MS and Reddy JK (1987). Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 8: 631-636.[Free Full Text]
• Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T., Hashimoto T., Lalwani ND, and Rao MS (1987). Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. USA 83: 1747-1751.[CrossRef][Web of Science]
• Reddy JK and Lalwani ND (1983). Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12: 1-58.[Medline] [Order article via Infotrieve]
• Reisenbichler H. and Eckl PM (1993). Genotoxic effects of selected peroxisome proliferators. Mutat. Res. 286: 135-144.[Web of Science][Medline] [Order article via Infotrieve]
• Sausen PJ, Lee DC, Rose ML, and Cattley RC (1995). Elevated 8-hydroxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to mitochondrial alterations. Carcinogenesis 16: 1795-1801.[Abstract/Free Full Text]
• Schulte-Hermann R., Parzefall W., and Bursch W. (1987). Role of stimulation of liver growth by chemicals in hepatocarcinogenesis. Banbury Rep. 25: 91-106.
• Styles JA (1993). Detection and quantification of ploidy, nuclearity and DNA synthesis in rat hepatocytes after administration of a peroxisome proliferator. Env. Health Perspect. 101: 225-227.
• Styles JA, Kelly MD, Pritchard NR, and Elcombe CR (1990). Acute hyperplasia and peroxisome proliferation induced by methyl clofenapate: A species comparison and implications for liver carcinogenesis. Prog. Clin. Biol. Res. 331: 385-393.[Web of Science][Medline] [Order article via Infotrieve]
• Takagi A., Sai, K., Umemura T., Hasegawa R., and Kurokawa Y. (1990). Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate. Cancer Lett. 53: 33-38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tamura J., Tanaka J., Fujita K., Yoshida M., Kasamatsu T., Arii S., and Tobe T. (1992). Cell kinetics of regenerating liver after 70% hepatectomy in rats: 2-Color flow cytometric analysis. HPB Surg. 5: 103-114.[CrossRef][Medline] [Order article via Infotrieve]
• Vitale M., Rizzoli R., Mazzotti G., Zamai L., Galanzi A., Rizzi E., Manzoli L., Matteucci A., and Papa S. (1991). Characterization and cell cycle kinetics of hepatocytes during rat liver regeneration: In vivo BrdU incorporation analyzed by flow cytometry and electron microscopy. Cell Prolif. 24: 331-338.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wada N., Marsman DS, and Popp JA (1992). Dose related effect of the hepatocarcinogens, Wy-14,643, on peroxisomes and cell replication. Fund. Appl. Toxicol. 18: 149-154.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Weghorst CM, Henneman JR, and Ward JM (1991). Dose response of hepatic and renal DNA synthetic rates to continuous exposure of bromodeoxyuridine (BrdU) via slow-release pellets or osmotic minipumps in male B6C3F1 mice. J. Histochem. Cytochem. 39: 177-184.[Abstract]
• Weinstein IB (1991). Mitogenesis is only one factor in carcinogenesis. Science 251: 387-388.[Free Full Text]
• Wolf HK and Michalopoulos GK (1992). Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: A study of proliferating cell nuclear antigen expression. Hepatology 15: 707-713.[Web of Science][Medline] [Order article via Infotrieve]
• Yeldandi AV, Milano M., Subbarao V., Reddy JK, and Rao MS (1989). Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett. 47: 21-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 25, No. 2, 165-176 (1997)
DOI: 10.1177/019262339702500206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF]

				S. C. Hasmall and R. A. Roberts The Nongenotoxic Hepatocarcinogens Diethylhexylphthalate and Methylclofenapate Induce DNA Synthesis Preferentially in Octoploid Rat Hepatocytes Toxicol Pathol, July 1, 2000; 28(4): 503 - 509. [Abstract] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lalwani, N. D. Articles by De La Iglesia, F. A. Search for Related Content PubMed PubMed Citation Articles by Lalwani, N. D. Articles by De La Iglesia, F. A. Social Bookmarking                         What's this?